TM Topic 183 - Tell me a secret
"The Kronos Science Laboratory is real, put the name in Google and you'll find us. I would link it here but I don't want them to track back to this LJ for obvious reasons. The article below is also very real. I thought it was time to show you all some of the work I've been doing."
Last month... headquarters of my lab.
At the headquarters of the Kronos Science Laboratory, its founder stood very still as the research team excitably informed him of the results. When they finally stopped speaking he simply nodded before turning to face the open expanse of glass. The view was panoramic, encompassing the city as well as the mountains off in the distance.
He smiled unabashedly once his back was to them. He had waited so patiently for this since he'd started financing the research some twenty years ago. Now he could bask in the knowledge that he was one major step closer to his goal.
He turned slowly around to face the researchers and doctors who were waiting with bated breath for him to give the green light to move ahead with the announcement. "Gentlemen, I know you've all worked very hard on this project. You all deserve far more than my thanks. I plan to take measures to see you all get exactly what you deserve." He nodded and smiled congenially. "Make the necessary arrangements for the news conference. You're the ones I want there, you should take the credit. I'll be happy to watch from the sidelines."
He moved around the large desk and congratulated his lead team, one at a time, with a firm handshake and words of praise.
The next day he turned on CNN to watch the news event. He then picked up the newspaper and could hardly contain his smile as he read.
The Arizona Republic
Scientists find gene link to Alzheimer's
Thu Jun 7, 6:47 PM ET
PHOENIX - A team of Arizona researchers think they've found a gene that could help better predict a person's risk of developing Alzheimer's disease
The gene - called GAB2 - seems to affect the odds that some people will get the progressive neurological disease that afflicts about 5 million Americans, according to the research team led by the Translational Genomics Research Institute and Banner Alzheimer's Institute.
"This is a major breakthrough in Alzheimer's genetic research that will have an impact on the clinical treatment of the disease," said Dr. Dietrich Stephan, director of TGen's neurogenomics division.
Researchers here believe the study marks a new milestone for genetic research of Alzheimer's disease because it used a high-powered computer chip to measure more than a half-million genetic variations, the most robust such study to date.
Alzheimer's triggers memory lapses, clouds the thought process and leads to confusion and death in older adults.
About 78,000 Arizonans suffered from Alzheimer's in 2000, a number expected to jump to 130,000 by 2025, according to Banner Alzheimer's Institute.
Researchers worldwide are not sure what causes the disease. They do know that sufferers' brains are harmed by plaques and tangles that block signals and ultimately cause cells to shrink and die.
TGen's Stephan began investigating the possibility of conducting an ambitious study of the disease three years ago.
He sought funding from the Kronos Science Laboratory in Phoenix, which provided most of the money for the $5 million project.
In turn, Kronos secured the intellectual property rights from the Arizona study and is seeking patent protection for the GAB2 gene and its role in the onset of Alzheimer's.
The study is the latest to draw national attention for the gene investigators at TGen, which launched here five years ago as part of a push to build Arizona's research prowess.
Other significant studies conducted by TGen and collaborators in Arizona include genetic tests relating to pancreatic cancer and amyotrophic lateral sclerosis, also known as Lou Gehrig's disease.
ooc: Note to readers: The lab and article are real and I in no way am making light of this very important work. This is only a fictional character working in a writing community. No harm is intended.
Last month... headquarters of my lab.
At the headquarters of the Kronos Science Laboratory, its founder stood very still as the research team excitably informed him of the results. When they finally stopped speaking he simply nodded before turning to face the open expanse of glass. The view was panoramic, encompassing the city as well as the mountains off in the distance.
He smiled unabashedly once his back was to them. He had waited so patiently for this since he'd started financing the research some twenty years ago. Now he could bask in the knowledge that he was one major step closer to his goal.
He turned slowly around to face the researchers and doctors who were waiting with bated breath for him to give the green light to move ahead with the announcement. "Gentlemen, I know you've all worked very hard on this project. You all deserve far more than my thanks. I plan to take measures to see you all get exactly what you deserve." He nodded and smiled congenially. "Make the necessary arrangements for the news conference. You're the ones I want there, you should take the credit. I'll be happy to watch from the sidelines."
He moved around the large desk and congratulated his lead team, one at a time, with a firm handshake and words of praise.
The next day he turned on CNN to watch the news event. He then picked up the newspaper and could hardly contain his smile as he read.
The Arizona Republic
Scientists find gene link to Alzheimer's
Thu Jun 7, 6:47 PM ET
PHOENIX - A team of Arizona researchers think they've found a gene that could help better predict a person's risk of developing Alzheimer's disease
The gene - called GAB2 - seems to affect the odds that some people will get the progressive neurological disease that afflicts about 5 million Americans, according to the research team led by the Translational Genomics Research Institute and Banner Alzheimer's Institute.
"This is a major breakthrough in Alzheimer's genetic research that will have an impact on the clinical treatment of the disease," said Dr. Dietrich Stephan, director of TGen's neurogenomics division.
Researchers here believe the study marks a new milestone for genetic research of Alzheimer's disease because it used a high-powered computer chip to measure more than a half-million genetic variations, the most robust such study to date.
Alzheimer's triggers memory lapses, clouds the thought process and leads to confusion and death in older adults.
About 78,000 Arizonans suffered from Alzheimer's in 2000, a number expected to jump to 130,000 by 2025, according to Banner Alzheimer's Institute.
Researchers worldwide are not sure what causes the disease. They do know that sufferers' brains are harmed by plaques and tangles that block signals and ultimately cause cells to shrink and die.
TGen's Stephan began investigating the possibility of conducting an ambitious study of the disease three years ago.
He sought funding from the Kronos Science Laboratory in Phoenix, which provided most of the money for the $5 million project.
In turn, Kronos secured the intellectual property rights from the Arizona study and is seeking patent protection for the GAB2 gene and its role in the onset of Alzheimer's.
The study is the latest to draw national attention for the gene investigators at TGen, which launched here five years ago as part of a push to build Arizona's research prowess.
Other significant studies conducted by TGen and collaborators in Arizona include genetic tests relating to pancreatic cancer and amyotrophic lateral sclerosis, also known as Lou Gehrig's disease.
ooc: Note to readers: The lab and article are real and I in no way am making light of this very important work. This is only a fictional character working in a writing community. No harm is intended.